Quebec platelet disorder: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Quebec platelet disorder | |||
| image = [[File:Autosomal_dominant_-_en.svg|200px]] | |||
| caption = [[Autosomal dominant]] pattern is the mode of inheritance for Quebec platelet disorder | |||
| field = [[Hematology]] | |||
| symptoms = [[Bleeding]] | |||
| complications = [[Anemia]], [[hemorrhage]] | |||
| onset = [[Childhood]] | |||
| duration = [[Lifelong]] | |||
| causes = [[Genetic mutation]] | |||
| risks = Family history of the disorder | |||
| diagnosis = [[Genetic testing]], [[blood test]] | |||
| differential = Other [[platelet function disorder]]s | |||
| treatment = [[Antifibrinolytic]] agents, [[platelet transfusion]] | |||
| prognosis = Variable, depending on severity | |||
| frequency = Rare | |||
}} | |||
'''Quebec Platelet Disorder''' ('''QPD''') is a rare [[bleeding disorder]] that is characterized by a deficiency in the [[blood platelets]]' ability to clot. This disorder is unique to certain families in the province of [[Quebec]], [[Canada]], hence its name. | '''Quebec Platelet Disorder''' ('''QPD''') is a rare [[bleeding disorder]] that is characterized by a deficiency in the [[blood platelets]]' ability to clot. This disorder is unique to certain families in the province of [[Quebec]], [[Canada]], hence its name. | ||
== Symptoms == | == Symptoms == | ||
The symptoms of Quebec Platelet Disorder include [[bruising]], [[nosebleeds]], [[gastrointestinal bleeding]], and [[menorrhagia]] (heavy menstrual bleeding). These symptoms are due to the inability of the blood platelets to clot properly, leading to excessive bleeding. | The symptoms of Quebec Platelet Disorder include [[bruising]], [[nosebleeds]], [[gastrointestinal bleeding]], and [[menorrhagia]] (heavy menstrual bleeding). These symptoms are due to the inability of the blood platelets to clot properly, leading to excessive bleeding. | ||
== Causes == | == Causes == | ||
Quebec Platelet Disorder is caused by a mutation in the [[gene]] that codes for the production of [[plasminogen activator inhibitor-1]] (PAI-1), a protein that inhibits the breakdown of blood clots. This mutation results in an overproduction of PAI-1, leading to a decrease in the ability of the blood platelets to clot. | Quebec Platelet Disorder is caused by a mutation in the [[gene]] that codes for the production of [[plasminogen activator inhibitor-1]] (PAI-1), a protein that inhibits the breakdown of blood clots. This mutation results in an overproduction of PAI-1, leading to a decrease in the ability of the blood platelets to clot. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of Quebec Platelet Disorder is based on the presence of the characteristic symptoms, a family history of the disorder, and laboratory tests that show an increase in the level of PAI-1 in the blood. | The diagnosis of Quebec Platelet Disorder is based on the presence of the characteristic symptoms, a family history of the disorder, and laboratory tests that show an increase in the level of PAI-1 in the blood. | ||
== Treatment == | == Treatment == | ||
The treatment of Quebec Platelet Disorder is aimed at controlling the symptoms and preventing bleeding episodes. This may include the use of [[antifibrinolytic drugs]], which help to stabilize blood clots and prevent them from breaking down. | The treatment of Quebec Platelet Disorder is aimed at controlling the symptoms and preventing bleeding episodes. This may include the use of [[antifibrinolytic drugs]], which help to stabilize blood clots and prevent them from breaking down. | ||
== See also == | == See also == | ||
* [[Bleeding disorder]] | * [[Bleeding disorder]] | ||
* [[Blood platelets]] | * [[Blood platelets]] | ||
* [[Plasminogen activator inhibitor-1]] | * [[Plasminogen activator inhibitor-1]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Bleeding disorders]] | [[Category:Bleeding disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Health in Quebec]] | [[Category:Health in Quebec]] | ||
{{stub}} | {{stub}} | ||
Latest revision as of 22:34, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Quebec platelet disorder | |
|---|---|
| Error creating thumbnail: | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Bleeding |
| Complications | Anemia, hemorrhage |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the disorder |
| Diagnosis | Genetic testing, blood test |
| Differential diagnosis | Other platelet function disorders |
| Prevention | N/A |
| Treatment | Antifibrinolytic agents, platelet transfusion |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
Quebec Platelet Disorder (QPD) is a rare bleeding disorder that is characterized by a deficiency in the blood platelets' ability to clot. This disorder is unique to certain families in the province of Quebec, Canada, hence its name.
Symptoms[edit]
The symptoms of Quebec Platelet Disorder include bruising, nosebleeds, gastrointestinal bleeding, and menorrhagia (heavy menstrual bleeding). These symptoms are due to the inability of the blood platelets to clot properly, leading to excessive bleeding.
Causes[edit]
Quebec Platelet Disorder is caused by a mutation in the gene that codes for the production of plasminogen activator inhibitor-1 (PAI-1), a protein that inhibits the breakdown of blood clots. This mutation results in an overproduction of PAI-1, leading to a decrease in the ability of the blood platelets to clot.
Diagnosis[edit]
The diagnosis of Quebec Platelet Disorder is based on the presence of the characteristic symptoms, a family history of the disorder, and laboratory tests that show an increase in the level of PAI-1 in the blood.
Treatment[edit]
The treatment of Quebec Platelet Disorder is aimed at controlling the symptoms and preventing bleeding episodes. This may include the use of antifibrinolytic drugs, which help to stabilize blood clots and prevent them from breaking down.
See also[edit]
References[edit]
<references />
